HWP
EBS icon

Hibernia Wealth Partners’s Emergent Biosolutions EBS Stock Holding History

Hibernia Wealth Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$1.36K – 142
2023
Q3 		$1.36K Buy
+400
New +$2.22K ﹤0.01% 276

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hibernia Wealth Partners's EBS Position: Q4 2023 in Review

Hibernia Wealth Partners sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 400 shares — an estimated $1.36K sold.

Hibernia Wealth Partners first reported a position in EBS in Q3 2023 and held it in 1 quarter. The position peaked at $1.36K in Q3 2023. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

  • Hibernia Wealth Partners reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
  • Hibernia Wealth Partners sold 400 Emergent Biosolutions shares in Q4 2023, an estimated $1.36K.
  • Hibernia Wealth Partners first reported a position in Emergent Biosolutions in Q3 2023 and held it in 1 quarter.
  • Hibernia Wealth Partners's Emergent Biosolutions position peaked at $1.36K in Q3 2023.
  • 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Hibernia Wealth Partners's 13F filing for Q4 2023, filed 19 Jan 2024.